PUBLISHER: BCC Research | PRODUCT CODE: 1266826
PUBLISHER: BCC Research | PRODUCT CODE: 1266826
The global market for thawing systems is estimated to increase from $242.2 million in 2022 to reach $341.4 million by 2027, at a compound annual growth rate (CAGR) of 7.1% from 2022 through 2027.
The global market for thawing systems for blood sampling is estimated to increase from $151.7 million in 2022 to reach $207.3 million by 2027, at a compound annual growth rate (CAGR) of 6.4% from 2022 through 2027.
The global market for thawing systems for embryo and ovum sampling is estimated to increase from $42.5 million in 2022 to reach $65.4 million by 2027, at a CAGR of 9.0% from 2022 through 2027.
The scope of this study entails the worldwide market for thawing systems. The report covers the entire market for thawing systems, which incorporates four sample types: blood, embryo and ovum, semen, and stem cells. Based on the end user, thawing systems are divided into blood bank and transfusion centers, hospitals and diagnostic centers, biotechnology and pharma companies, and research and academic institutes.
By geographical region, the market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. For market estimates, data has been provided for the year 2021 as the base year, with forecasts for 2022-2027. Estimated values are based on device manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.